Livzon Pharmaceutical Group AI Stock Analysis
Livzon Pharmaceutical Group (LVZPF) AI Stock Analysis
Livzon Pharmaceutical Group
(Other OTC:LVZPF)
No summary available
Livzon Pharmaceutical Group (LVZPF) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- $6.06B
- Dividend Yield
- 3.86%
- Average Volume (3M)
- ―
- Price to Earnings (P/E)
- 18.1
- Beta (1Y)
- 0.29
- Revenue Growth
- -9.78%
- EPS Growth
- -23.43%
- Country
- US
- Employees
- 8,878
- Sector
- General
- Sector Strength
- 55
- Industry
- Drug Manufacturers - Specialty & Generic
Livzon Pharmaceutical Group Business Overview & Revenue Model
Company Description
Livzon Pharmaceutical Group Inc., founded in Zhuhai, China, in 1985, is a prominent enterprise dedicated to the research, development, manufacturing, and global commercialization of a wide range of pharmaceutical products, including finished drugs, a...
Livzon Pharmaceutical Group Peers Comparison
Overall Rating
HK:332079Outperform
HK:086761Neutral
HK:087457Neutral
HK:051255Neutral
HK:393354Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 79Outperform | HKD 27.61B | 5.86 | 7.92% | 5.45% | 7.94% | 52.83% | |
| 61Neutral | HKD 24.59B | 13.82 | 8.60% | 3.41% | 14.80% | -2.88% | |
| 57Neutral | HKD 34.76B | 14.55 | 5.57% | 6.86% | 6.00% | -23.05% | |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| 55Neutral | HKD 15.32B | 13.46 | 6.61% | 3.92% | 7.35% | -45.49% | |
| 54Neutral | HKD 14.75B | 22.89 | 3.12% | 6.33% | -12.86% | -83.10% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| LVZPF | Livzon Pharmaceutical Group Class H | 3.80 | -0.94 | -19.77% | |
| HK:3933 | The United Laboratories International | 7.49 | -3.86 | -34.00% | |
| HK:0867 | China Medical System Holdings | 10.08 | -3.24 | -24.31% | |
| HK:0874 | Guangzhou Baiyunshan Pharmaceutical Holdings Company Class H | 12.58 | -5.83 | -31.66% | |
| HK:3320 | China Resources Pharmaceutical Group Ltd. | 4.39 | -0.24 | -5.24% | |
| HK:0512 | Grand Pharmaceutical Group Limited | 4.32 | -3.68 | -46.02% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
